Enantioselective (3+2)-Annulation of β-Keto Esters with Azoalkenes towards Bicyclic Dihydropyrroles via Cooperative Palladium and Brønsted Acid Catalysis
Synlett · 04.06.2024 · 35 (09) · 997-1000
DOI: 10.1055/a-2210-0973 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synlett, erschienen am 04.06.2024. Verfasst von Christoph Schneider und 3 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
A cooperative catalytic process through palladium and Brønsted acid activation is developed for the conjugate addition of cyclic β-keto esters to azoalkenes directly followed by hemiaminal formation upon cyclization. This transformation is enabled by utilizing chiral Pd-aqua complexes as combined Brønsted acid–base catalysts. Thus, bicyclic and highly functionalized dihydropyrroles with two contiguous quaternary stereogenic centers are formed in excellent yields as single diastereomers and with exceptional enantioselectivity.
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Schneider, C., Friedmann, T., Mireles-Chávez, D. A., & Walter, F. L. (2024). Enantioselective (3+2)-Annulation of β-Keto Esters with Azoalkenes towards Bicyclic Dihydropyrroles via Cooperative Palladium and Brønsted Acid Catalysis. Synlett, 35(09), 997-1000. https://doi.org/10.1055/a-2210-0973
Vancouver
Schneider C, Friedmann T, Mireles-Chávez DA, Walter FL. Enantioselective (3+2)-Annulation of β-Keto Esters with Azoalkenes towards Bicyclic Dihydropyrroles via Cooperative Palladium and Brønsted Acid Catalysis. Synlett. 2024;35(09):997-1000. doi:10.1055/a-2210-0973
BibTeX
@article{Schneider2024,
author = {Schneider, Christoph and Friedmann, Till and Mireles-Chávez, Daniel A. and Walter, Frederik L.},
title = {Enantioselective (3+2)-Annulation of β-Keto Esters with Azoalkenes towards Bicyclic Dihydropyrroles via Cooperative Palladium and Brønsted Acid Catalysis},
journal = {Synlett},
year = {2024},
volume = {35},
number = {09},
pages = {997--1000},
doi = {10.1055/a-2210-0973}
}
EUVIMED